Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Diffuse Large B-cell Lymphoma
In brief
This is a phase 3, multicenter, randomized, double-blind, placebo-controlled trial designed to compare the efficacy and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed DLBCL
Key facts
- Study ID
- NCT04824092
- Run by
- Incyte Corporation
- People needed
- 899
- Starts
- 2021-05-11
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2026-04-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MorphoSys Research Site — Anaheim, California, United States
- MorphoSys Research Site — Clovis, California, United States
- MorphoSys Research Site — Fullerton, California, United States
- MorphoSys Research Site — Harbor City, California, United States
- MorphoSys Research Site — Los Angeles, California, United States
- MorphoSys Research Site — San Diego, California, United States
- MorphoSys Research Site — Whittier, California, United States
- MorphoSys Research Site — Aurora, Colorado, United States
- MorphoSys Research Site — Jacksonville, Florida, United States
- MorphoSys Research Site — Honolulu, Hawaii, United States
- MorphoSys Research Site — Wichita, Kansas, United States
- MorphoSys Research Site — Lexington, Kentucky, United States
- MorphoSys Research Site — Louisville, Kentucky, United States
- MorphoSys Research Site — Baltimore, Maryland, United States
- MorphoSys Research Site — Bethesda, Maryland, United States
- MorphoSys Research Site — Columbia, Maryland, United States
- MorphoSys Research Site — Detroit, Michigan, United States
- MorphoSys Research Site — Minneapolis, Minnesota, United States
- MorphoSys Research Site — Rochester, Minnesota, United States
- MorphoSys Research Site — Kansas City, Missouri, United States
- MorphoSys Research Site — Lebanon, New Hampshire, United States
- MorphoSys Research Site — Florham Park, New Jersey, United States
- MorphoSys Research Site — Buffalo, New York, United States
- MorphoSys Research Site — Rochester, New York, United States
- MorphoSys Research Site — Daphne, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.